ArticleCancer biology & therapy2015

NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.

Chuigong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.